bioRxivCancer Biology
The mechanism of activation of monomeric B-Raf V600E
Abstract
Oncogenic mutations in the serine/threonine kinase B-Raf, particularly the V600E mutation, are frequent in cancer, making it a major drug target. Although much is known about B-Rafs active and inactive states, questions remain about the mechanism by which the protein changes between these two states. Here, we utilize molecular dynamics to investigate both wild-type and V600E B-Raf to gain mechanistic insights into the impact of the Val to Glu mutation. The results show that the wild-type and mutant follow similar activation pathways involving an extension of the activation loop and an inward motion of the C-helix. The V600E mutation, however, destabilizes the inactive state by disrupting hydrophobic interactions present in the wild-type structure while the active state is stabilized through the formation of a salt bridge between Glu600 and Lys507. Additionally, when the activation loop is extended, the C-helix is able to move between an inward and outward orientation as long as the DFG motif adopts a specific orientation. In that orientation Phe595 rotates away from the C-helix, allowing the formation of a salt bridge between Lys483 and Glu501. These mechanistic insights have implications for the development of new Raf inhibitors.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Function and evolution of B-Raf loop dynamics relevant to cancer recurrence under drug inhibition
G. A. Babbitt, M. L. Lynch, … A. O. Hudson·bioRxiv·Jan 13, 2020
- Identification and Characterization of a B-Raf Kinase Alpha Helix Critical for the Activity of MEK Kinase in MAPK Signaling
- Free energy and flexibility analysis of autoinhibited human BRAF
Jeremy O. B. Tempkin, Fikret Aydin, … Xiao‐Hua Zhang·Journal of Chemical Information and ModelingPeer-reviewed·Apr 21, 2026
- The Dimer-dependent Catalytic Activity of RAF Family Kinases Is Revealed Through Characterizing Their Oncogenic Mutants
- Characterization and inhibitor sensitivity of ARAF, BRAF, and CRAF complexes
Emre Tkacik, Dong Man Jang, … Michael J. Eck·bioRxiv·Aug 14, 2025
- Mechanism of Dimer Selectivity and Binding Cooperativity of BRAF inhibitors
J. Clayton, A. Romany, … J. Shen·bioRxiv·Dec 12, 2023